 |
|
|
| |
Pharmacokinetics of Bemnifosbuvir in Participants With Renal Impairment
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Xiao-Jian Zhou,1 Gaetano Morelli,2 Jean-Philippe LaFrance,3 Maureen Montrond,1
Shannan Lynch,1 Keith Pietropaolo,1 Bruce Belanger,1 Maria Arantxa Horga,1 and Janet Hammond1
1. Atea Pharmaceuticals Inc, Boston, USA; 2. Altasciences, Montreal, Canada;
3. Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montreal, Canada.
|
| |
|
|
|
|
|
